CDER New July 28, 2015

What's New on the FDA Drugs Site

July 27, 2015

• FDA Drug Safety Communication: FDA evaluating the risk of brain deposits with repeated use of gadolinium-based contrast agents for magnetic resonance imaging (MRI)
• Drug Firm Annual Registration Status (updated)
• Drug Firm Annual Registration Status Download File (updated)
• FDA Drug Safety Communication (Spanish): La FDA advierte sobre una seria condición pulmonar en niños y recién nacidos tratados con Proglycem (diazóxido)
• Moses Lake Professional Pharmacy Issues Voluntary Recall of Unexpired Sterile Human and Veterinary Compounded Drugs Due to Lack of Sterility Assurance
• National Drug Code Directory
• Request for Quality Metrics Guidance for Industry (PDF - 251KB)